Actively Recruiting
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Led by Northern Jiangsu People's Hospital · Updated on 2025-10-03
30
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In this study,the researchers compared the changes in immune function-related indicators in patients with liver cirrhosis following laparoscopic partial splenectomy,to determine whether this surgical intervention can enhance postoperative immune function and thereby improve patient outcomes.
CONDITIONS
Official Title
Laparoscopic Partial Splenectomy for Hypersplenism in Liver Cirrhosis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of cirrhosis by clinical, radiological, or histologic methods
- Presence of splenomegaly with secondary hypersplenism
- History of gastroesophageal variceal bleeding
- Provided informed consent to participate in the study
You will not qualify if you...
- Presence of hepatocellular carcinoma or any other malignancy
- Child-Pugh grade C liver disease
- Recent peptic ulcer disease
- History of hemorrhagic stroke
- Pregnancy
- Uncontrolled hypertension
- Human immunodeficiency virus (HIV) infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinical Medical College of Yangzhou University
Yangzhou, Jiangsu, China, 225001
Actively Recruiting
Research Team
G
Guo-Qing Jiang
CONTACT
D
Dou-Sheng Bai
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here